Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- University of Washington
- Yale University
- Umeå University
- Stanford University
- University of Minnesota
- University of North Carolina at Chapel Hill
- Cornell University
- Nencki Institute of Experimental Biology
- St Jude Children's Research Hospital
- University of Maryland, Baltimore
- Baylor College of Medicine
- Heidelberg University
- Karolinska Institutet (KI)
- King's College London
- Northeastern University
- Rutgers University
- The University of Arizona
- University of California, Los Angeles
- CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences
- Delft University of Technology (TU Delft)
- FAPESP - São Paulo Research Foundation
- Fondazione per l'Istituto oncologico di ricerca IOR
- German Cancer Research Center in the Helmholtz Association (DKFZ)
- Harvard University
- Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
- INSERM
- Josep Carreras Leukaemia Research Institute (IJC)
- KU LEUVEN
- Lunds universitet
- Medizinische Universitaet Wien
- Michigan State University
- New York University
- Oak Ridge National Laboratory
- Research Center for Molecular Medicine (CeMM), ÖAW
- The International Institute of Molecular Mechanisms and Machines Polish Academy of Sciences
- The University of North Carolina at Chapel Hill
- The University of Texas at Dallas
- UNIVERSITY OF HELSINKI
- UNIVERSITY OF VIENNA
- University College Dublin
- University Medical Center Utrecht (UMC Utrecht)
- University of Colorado
- University of Copenhagen
- University of Illinois Chicago
- University of Michigan - Ann Arbor
- University of Texas at Dallas
- Université de Reims Champagne Ardenne
- VIB
- Washington University in St. Louis
- Yale University - Department of Genetics
- 40 more »
- « less
-
Field
-
The International Institute of Molecular Mechanisms and Machines Polish Academy of Sciences | Poland | about 2 months ago
. The project will involve designing and executing experiments using mammalian cell biology, CRISPR/Cas9 genome engineering, molecular biology, protein biochemistry, quantitative proteomics, and functional
-
biology, genome engineering, CRISPR-based screening, functional genomics, or C. elegans genetics are particularly encouraged to apply. Minimum Education and Experience Ph.D in a related field. Candidates
-
factor 2 in chronic lymphocytic leukemia (CLL). To achieve the goal of this project, state-of-the-art methods like CRISPR technology will be employed to perturb the expression and/or activity of TNFR2
-
this, we use zebrafish CRISPR-generated mutants to perform high-throughput functional screens. The postdoctoral associate will also support other tasks related to the team’s research, including the following
-
as well as MSc and PhD programmes. Further information may be found at: http://www.kcl.ac.uk/physics About the role: We are seeking a highly motivated and experienced researcher, holding a PhD in
-
development. Candidates with expertise in cell biology, genome engineering, CRISPR-based screening, functional genomics, or C. elegans genetics are particularly encouraged to apply. Create a Job Match for
-
Engineering – 20% • Use shRNA/CRISPR gene-targeting approaches to validate novel targets identified through secondary, custom-designed siRNA library screening. Laboratory Management and Scholarly
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 2 months ago
measurements of mucus transport, which may include particle transport assays and optical coherence tomography. Related work may include single-cell RNA/ATAC sequencing, RNA in situ hybridization, and CRISPR/Cas9
-
Sciences Internal Number: 1148598 Position Summary Postdoctoral positions funded by the NIH and MSU Research Foundation are open in the laboratory of Dr. Dohun Pyeon (http://www.pyeonlab.org/ ) at Michigan
-
the department of Pathology & Immunology at WashU in St. Louis to discover new pathways in the regulation of type-2 immunity. We have recently used cutting-edge CRISPR screens to identify new regulators of ILC2